Blau Farmacêutica Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	45.6	33.32	31.5	14.11	51.86
Short-Term Investments	-	-	375.82	629.53	870.96
Trading Asset Securities	569.49	459.56	-	-	-
Cash & Short-Term Investments	615.09	492.87	407.31	643.65	922.82
Cash Growth	24.80%	21.00%	-36.72%	-30.25%	330.52%
Accounts Receivable	458.47	476.75	453.56	420.61	331.79
Other Receivables	129.54	42.5	64.35	44.58	13.66
Receivables	588.02	519.25	517.91	465.19	345.45
Inventory	694.13	606.19	628.65	569.02	416.85
Other Current Assets	-	57.85	-	-	11.35
Total Current Assets	1,897	1,676	1,554	1,678	1,696
Property, Plant & Equipment	997.08	829.04	738.71	542.48	371.58
Long-Term Investments	-	265.16	265.19	-	0.04
Goodwill	151.66	151.66	151.66	143.24	143.24
Other Intangible Assets	67.86	53.81	24.83	16.57	5.75
Long-Term Deferred Tax Assets	77.8	84.52	81.53	-	-
Long-Term Deferred Charges	397.6	282.28	177.58	74.25	49.82
Other Long-Term Assets	45.81	69.12	60.17	44.65	61.14
Total Assets	3,635	3,412	3,054	2,499	2,328
Accounts Payable	266.38	286	179.92	163.64	116.43
Accrued Expenses	89.21	90.21	55.62	56.78	55.2
Short-Term Debt	94.49	1.87	2.3	-	41.73
Current Portion of Long-Term Debt	184.03	65.1	67.92	79.87	49.82
Current Portion of Leases	7.07	6.39	4.8	3.67	2.11
Current Income Taxes Payable	0.03	8.92	-	19.44	19.99
Other Current Liabilities	127.24	79.46	25.38	47.71	57.72
Total Current Liabilities	768.45	537.94	335.93	371.11	343.01
Long-Term Debt	283.33	450	500	200	272.5
Long-Term Leases	30.21	35.59	33.52	28.17	8.35
Long-Term Deferred Tax Liabilities	221.98	170.2	125.64	35.02	18.25
Other Long-Term Liabilities	75.32	67.33	63.2	46.81	51.05
Total Liabilities	1,379	1,261	1,058	681.11	693.16
Common Stock	1,717	1,317	1,317	1,317	1,317
Retained Earnings	612.28	899.32	744.37	562.8	325.13
Treasury Stock	-42.89	-42.89	-42.89	-39.9	-
Comprehensive Income & Other	-14.23	-9.05	-16.62	-17.36	-5.45
Total Common Equity	2,272	2,164	2,001	1,822	1,636
Minority Interest	-16.02	-13.33	-6.22	-4.22	-1.4
Shareholders' Equity	2,256	2,151	1,995	1,818	1,635
Total Liabilities & Equity	3,635	3,412	3,054	2,499	2,328
Total Debt	599.13	558.95	608.54	311.71	374.52
Net Cash (Debt)	15.95	-66.08	-201.22	331.93	548.3
Net Cash Growth	-	-	-	-39.46%	-
Net Cash Per Share	0.07	-0.29	-0.87	1.44	2.35
Filing Date Shares Outstanding	230.98	230.98	230.98	231.18	233.21
Total Common Shares Outstanding	230.98	230.98	230.98	231.18	233.21
Working Capital	1,129	1,138	1,218	1,307	1,353
Book Value Per Share	9.84	9.37	8.66	7.88	7.02
Tangible Book Value	2,052	1,959	1,825	1,662	1,487
Tangible Book Value Per Share	8.88	8.48	7.90	7.19	6.38
Machinery	440.23	338.57	302.14	170.92	135.22
Construction In Progress	335.21	296.26	257.03	210.19	194.06

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.